07/06/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

07/06/2024

Jun 7, 2024, 05:26 | Blog
Erman Akkus: Biomarkers and targeted treatments
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: "Biomarkers and targeted…
Jun 7, 2024, 05:15 | Insight
Richard Shadyac: Brands that partner with St. Jude Children's Research Hospital experience a lift in trust and favorability
Richard Shadyac, President and CEO of ALSAC, shared on LinkedIn: “It's true — a 2023 Porter-Novelli…
Jun 7, 2024, 05:08 | Blog
Donald Carlino: I've embarked on a new career journey as Manager of US Advocacy at Novocure
Donald Carlino, Manager, US Advocacy at Novocure, shared on their LinkedIn: ''I'm thrilled to announce…
Jun 7, 2024, 04:51 | Blog
Paolo Tarantino: DB06 showed relevant activity with T-DXd for MBC
Paolo Tarantino shared a post on X: "DB06 showed relevant activity with T-DXd for the 1L…
Jun 7, 2024, 04:14 | Cancer Types
Adenocarcinoma of the Lung: What patients should know about
What is Adenocarcinoma of the Lung? Adenocarcinoma of the lung is the most common type…
Jun 7, 2024, 03:12 | Blog
Pashtoon Kasi: Chalabi Plot now in print
Pashtoon Kasi shared a post on X: "Chalabi Plot now in print. Congratulations Myriam Chalabi/article/ With an…
Jun 7, 2024, 03:10 | Blog
Isabel Mestres: I wish I were one of the 12 women granted $20 million by Melinda French Gates
Isabel Mestres recently shared a post on LinkedIn: "I wish I were one of the…
Jun 7, 2024, 02:53 | Blog
Fumiko Ladd Chino: Sharing this fundraiser to the Radiation Oncology community
Fumiko Ladd Chino shared a post on X: "Sharing this fundraiser to the Radiation Oncology onctwitter…
Jun 7, 2024, 02:43 | Blog
Emma B. Holliday: Feeling inspired by Dr. Buchholz’s phenominal lecture on physician leadership
Emma B. Holliday, Radiation Oncologist at the University of Texas MD Anderson Cancer Center, made the…
Jun 7, 2024, 02:29 | Blog
Arndt Vogel: Lenvatinib Plus Pembrolizumab vs SOC in Previously Treated mCRC
Arndt Vogel shared a post on X: "Lenvatinib Plus Pembrolizumab vs SOC in Previously Treated mCRC…
All: 110 Posts: 81 - 90